WASHINGTON –Wilkinson Stekloff enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.
Wilkinson Stekloff Announces Three Promotions
June 6, 2019
WASHINGTON — Wilkinson Stekloff today announced three promotions. Kieran Gostin and Ralia Polechronis were elected to the partnership, and Andrew Croner was promoted to counsel. The promotions took effect on June 1. “Kieran, Ralia, and Andrew have each in their own ways played an integral role in many of the firm’s successes, from inside the courtroom to mentoring fellow colleagues,” said founding partner Alex Walsh. “We are truly fortunate to have them in the Wilkinson Stekloff family. Their well-deserved promotions are a testament to their value to the firm.” An experienced defense attorney, Kieran has represented government and corporate clients in products liability, antitrust, data breach, copyright, national security, First Amendment, Privacy Act, Administrative Procedure Act, and other complex civil litigation matters. Kieran recently helped lead a trial team that won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit (Farar et al. v. Bayer) …
Litigation Daily: “Killer Crosses: How Wilkinson Stekloff Partners Shredded Witnesses in $600M Save for Bayer”
February 26, 2019
After the Wilkinson Stekloff team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, Litigation Daily‘s Jenna Greene wrote about how Eskovitz and Walsh were “so good” at the cross-examinations that “the Wilkinson Stekloff team called no defense witnesses. They annihilated the case on crosses alone”: If cross-examination is an art form, then Wilkinson Stekloff name partners Alexandra Walsh and Sean Eskovitz (pictured above) are masters. The duo led a trial team defending Bayer AG, which faced a $600 million certified consumer class action over its One A Day multivitamin. The plaintiffs alleged Bayer made false and misleading claims that One A Day supported heart health, immunity and physical energy. How good were the cross-examinations? So good that that the Wilkinson Stekloff team called no defense witnesses. They annihilated the case on …
Wilkinson Stekloff Secures Trial Win for Bayer in $600 Million One A Day Class Action
WASHINGTON, D.C. — The Wilkinson Stekloff team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers. Without calling any witnesses in the defense case, the team relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses to convince the jury to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins. The jury deliberated for just an hour before returning a complete defense verdict. The class action suit, filed on behalf of purchasers of One A Day multivitamins in California, New York, and Florida, challenged as false and misleading Bayer’s claims that One A Day multivitamins support heart health, immunity, and physical energy. Plaintiffs originally sought over $4 billion in damages, which Wilkinson Stekloff successfully reduced to $600 million …
Wilkinson Stekloff Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers
January 7, 2019
WASHINGTON – Wilkinson Stekloff is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Stekloff’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Stekloff won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Stekloff, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Stekloff, led by Kosta Stojilkovic …
Wilkinson Stekloff’s Kosta Stojilkovic, Kieran Gostin Named to Law360’s “Rising Stars”
July 30, 2018
WASHINGTON – Wilkinson Stekloff’s Kosta Stojilkovic and Kieran Gostin were named to Law360’s “Rising Stars of 2018,” an honor for “attorneys under 40 whose legal accomplishments transcend their age.” Kosta Stojilkovic was recognized for his trial work, while Kieran Gostin was recognized for his work on products liability matters. “Kosta and Kieran’s well-deserved recognition underscores our firm’s philosophy of empowering younger attorneys to showcase their talent, regardless of age or seniority,” said Wilkinson Stekloff Founding Partner Sean Eskovitz. “Kosta and Kieran are litigation superstars, bringing great intellect, judgment, and energy to everything they do, and we are proud that they are leading the way for the next generation of trial lawyers.“ Law360’s Rising Stars for 2018 were selected from over 1,200 submissions and are “based on their career accomplishments in their respective disciplines.” Most recently, Kosta obtained a complete defense verdict in McNair v. NCAA, a high-profile defamation case. At …
Experienced Defense Attorney Kieran Gostin Promoted To Wilkinson Stekloff Counsel
January 12, 2018
WASHINGTON – Wilkinson Stekloff today announced that Kieran Gostin has been promoted to Counsel effective January 1, 2018. Since joining Wilkinson Stekloff as an associate, Kieran has used his breadth of experience representing government and corporate clients to secure major victories for Wilkinson Stekloff’s clients. Kieran most recently helped Bayer win the first state-court bellwether trial over the blood-thinner Xarelto; the trial court entered judgment for Bayer and Janssen notwithstanding a jury verdict in favor of the plaintiff. He also played a significant role in helping Bayer obtain victories in the first two federal MDL trials relating to Xarelto, with both juries returning complete defense verdicts in under two hours. Kieran’s promotion is a testament to the considerable talent Wilkinson Stekloff has amassed in under two years and the ongoing expansion of the firm. Since its inception, Wilkinson Stekloff has grown to nearly 40 lawyers and has quickly established itself …
- Page 2 of 2
- 1
- 2